- Xiaoke Wu, Kaijiang Yu, Yongchen Wang, Wanhai Xu, Hongli Ma, Yan Hou, Yue Li, Benzhi Cai, Liying Zhu, Min Zhang, Xiaoli Hu, Jingshu Gao, Yu Wang, Huichao Qin, Mingyan Zhao, Yong Zhang, Kang Li, Zhimin Du, Baofeng Yang, “The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol”, Engineering, 6, no. 10, 2020, 1199
- Daniel Ruzek, Tatjana Avšič Županc, Johannes Borde, Ales Chrdle, Ludek Eyer, Galina Karganova, Ivan Kholodilov, Nataša Knap, Liubov Kozlovskaya, Andrey Matveev, Andrew D. Miller, Dmitry I. Osolodkin, Anna K. Överby, Nina Tikunova, Sergey Tkachev, Joanna Zajkowska, “Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines”, Antiviral Research, 164, 2019, 23
- Evgeny B. Gorbunov, Gennady L. Rusinov, Evgeny N. Ulomsky, Vladimir L. Rusinov, Valery N. Charushin, Oleg N. Chupakhin, “C–H functionalization of triazolo[a]-annulated 8-azapurines”, Tetrahedron Letters, 57, no. 21, 2016, 2303
- Konstantin Savateev, Victor Fedotov, Ilya Butorin, Oleg Eltsov, Pavel Slepukhin, Evgeny Ulomsky, Vladimir Rusinov, Roman Litvinov, Denis Babkov, Elisaveta Khokhlacheva, Pyotr Radaev, Pavel Vassiliev, Alexandr Spasov, “Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents”, European Journal of Medicinal Chemistry, 185, 2020, 111808
- Olga V. Shabunina, Yaroslav K. Shtaitz, Dmitry S. Kopchuk, Alexey P. Krinochkin, Sougata Santra, Grigory V. Zyryanov, Zhuo Wang, Vladimir L. Rusinov, Oleg N. Chupakhin, “Synthesis of Novel 3-(Pyridin-4-yl)-1,2,4-Triazines, their Analogs and Study of the Activity Against Vaccinia Virus”, Chem Heterocycl Comp, 57, no. 4, 2021, 462
- T. V. Klimova, V. A. Shevyrin, A. V. Ivanova, A. N. Kozitsina, S. L. Deev, V. L. Rusinov, “Study of the Fragmentation of the Antiviral Drug Triazavirin in a Collision Cell under Electrospray Ionization Conditions”, J Anal Chem, 78, no. 14, 2023, 1921
- Sean Ekins, Thomas R. Lane, Peter B. Madrid, “Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond”, Pharm Res, 37, no. 4, 2020, 71
- Sergey V. Valiulin, Andrey A. Onischuk, Sergey N. Dubtsov, Anatoly M. Baklanov, Sergey V. An'kov, Maria E. Plokhotnichenko, Tatyana G. Tolstikova, Galina G. Dultseva, Vladimir L. Rusinov, Valery N. Charushin, Vasily M. Fomin, “Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections”, Journal of Pharmaceutical Sciences, 110, no. 3, 2021, 1316
- E. G Deeva, Leg Ivanovich Kiselev, Tatjana Ilinichna Melnikova, Aram Arutjunovich Shaldzhan, Petr Alexeevich Nekrasov, Alexey Sergeevich Kiselev, Ksenia Alexandrovna Zagorodnikova, Valeriy Nikolaevich Charushin, Vladimir Leonidovich Rusinov, Evgeniy Narcissovich Ulomsky, Oleg Nikolaevich Chupakhin, “NEW ANTIVIRAL DRUG TRIAZAVIRIN. RESULTS OF PHASE 1 CLINICAL TRIAL”, Epidemiology and Infectious Diseases, 18, no. 5, 2013, 20
- Vladimir L. Rusinov, Irina M. Sapozhnikova, Evgeny N. Ulomskii, Natalia R. Medvedeva, Vladimir V. Egorov, Oleg I. Kiselev, Ella G. Deeva, Andrey V. Vasin, Oleg N. Chupakhin, “Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins”, Chem Heterocycl Comp, 51, no. 3, 2015, 275